De Novo Protein Synthesis Is Required for Lytic Cycle Reactivation of Epstein-Barr Virus, but Not Kaposi's Sarcoma-Associated Herpesvirus, in Response to Histone Deacetylase Inhibitors and Protein Kinase C Agonists

Eitemau Tebyg

• Valproic Acid Antagonizes the Capacity of Other Histone Deacetylase Inhibitors To Activate the Epstein-Barr Virus Lytic Cycle
  gan: Daigle, Derek, et al.
  Cyhoeddwyd: (2011)
• Activation and Repression of Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycles by Short- and Medium-Chain Fatty Acids
  gan: Gorres, Kelly L., et al.
  Cyhoeddwyd: (2014)
• Epstein-Barr Virus Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication in Primary Effusion Lymphomas
  gan: Xu, Dongsheng, et al.
  Cyhoeddwyd: (2007)
• Histone Hyperacetylation Occurs on Promoters of Lytic Cycle Regulatory Genes in Epstein-Barr Virus-Infected Cell Lines Which Are Refractory to Disruption of Latency by Histone Deacetylase Inhibitors
  gan: Countryman, Jill K., et al.
  Cyhoeddwyd: (2008)
• A viral gene that activates lytic cycle expression of Kaposi’s sarcoma-associated herpesvirus
  gan: Sun, Ren, et al.
  Cyhoeddwyd: (1998)